2016_Head & Neck COURSE BOOK

Loco‐regional control – acc. RT DAHANCA 6 & 7 ‐ 1476 patients 100

6 Fx

80

70% 60%

rol (%)

60

5 Fx

al cont

40

P=0.0005

All

Failure

region

5 Fx 6 Fx

726 274 750 211

20

Loco‐

0

0

12

24

36

48

60

Time after treatment (months)

Overgaard et al.  Lancet 2003